EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Function of PNPLA3 I148M —Lessons From In Vivo Studies in Humans

Hannele Yki-Järvinen iD, Panu K Luukkonen iD

Liver International · 2025

DOI: 10.1111/liv.70047 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Liver International, 2025. Verfasst von Hannele Yki-Järvinen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Membrane Proteins, Lipase, Fatty Liver, Metabolic Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Finnish Government Research Fund, Academy of Finland, Early Career Investigator fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Steatotic liver disease (SLD) associated with insulin resistance (IR) and the metabolic syndrome (‘IR‐SLD’) increases the risk of liver disease, type 2 diabetes and cardiovascular disease (CVD). SLD associated with the PNPLA3 I148M variant (‘PNPLA3‐SLD’) also predisposes individuals to liver disease but protects against type 2 diabetes and CVD. Although in real life the two causes of SLD commonly co‐exist, the opposite effects of ‘IR‐SLD’ and ‘PNPLA3‐SLD’ on CVD and liver disease suggest their pathogenesis differs. Methods and Results This review summarises human data comparing the effects of ‘IR‐SLD’ and ‘PNPLA3‐SLD’ on the human liver lipidome, hepatic handling of fatty acids, pathways of intrahepatocellular triglyceride synthesis, circulating lipids and lipoproteins and adipose tissue inflammation. We also discuss how steatosis in PNPLA3 I148M carriers leads to defects in mitochondrial function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsLipaseFatty LiverMetabolic SyndromeHumansInsulin ResistanceLiverCardiovascular DiseasesDiabetes Mellitus, Type 2Lipid MetabolismGenetic Predisposition to DiseaseTriglyceridesAcyltransferasesPhospholipases A2, Calcium-Independent

Stichwörter der Autor:innen

adipose tissuecoagulation factorsde novo lipogenesisinsulin sensitivitylipidomelipids and lipoproteinslipolysisliver

Substanzen

PNPLA3 protein, humanMembrane ProteinsLipaseTriglyceridesAcyltransferasesPhospholipases A2, Calcium-Independent

Autor:innen und Institutionen

  • Department of Medicine, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Minerva Foundation Institute for Medical Research, Helsinki, Finland.
  • Abdominal Center, Helsinki University Hospital, Helsinki, Finland.

ORCID-Profile: Hannele Yki-Järvinen, Panu K Luukkonen

Förderung

  • Finnish Government Research Fund
  • Academy of Finland
  • Early Career Investigator fund
  • Finnish Medical Foundation
  • Novo Nordisk Foundation
  • Sigrid Juselius Foundation
  • Research Council of Finland
  • Suomen Lääketieteen Säätiö

Zitieren

APA

Yki-Järvinen, H., & Luukkonen, P. K. (2025). Function of PNPLA3 I148M —Lessons From In Vivo Studies in Humans. Liver International. https://doi.org/10.1111/liv.70047

Vancouver

Yki-Järvinen H, Luukkonen PK. Function of PNPLA3 I148M —Lessons From In Vivo Studies in Humans. Liver International. 2025. doi:10.1111/liv.70047

BibTeX
@article{YkiJrvinen2025,
  author = {Yki-Järvinen, Hannele and Luukkonen, Panu K},
  title = {Function of PNPLA3 I148M —Lessons From In Vivo Studies in Humans},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70047}
}
Kostenlos starten →